Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 235.614 million compared to CNY 390.693 million a year ago. Operating income was CNY 27.703 million compared to CNY 94.234 million a year ago. Net income was CNY 29.078 million compared to CNY 91.719 million a year ago. Basic earnings per share was CNY 0.03 compared to CNY 0.1 a year ago.